StockData
Humacyte, Inc. logo

Humacyte, Inc. (HUMA) stock

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.50−0.04 (-7.27%)

Close on Nov 17, 2026Market cap $139.18MP/E –Yield –

Humacyte shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Humacyte's shares outstanding was 234M at Jun 30, 2026. For fiscal 2025 it was 158M, up 33.5% from the year before. The highest annual figure on record is 158M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025158M+33.5%
FY2024Dec 31, 2024118M+14.6%
FY2023Dec 31, 2023103M+0.4%
FY2022Dec 31, 2022103M+157.8%
FY2021Dec 31, 202140M+593.2%
FY2020Dec 31, 20206M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026234M+50.7%
Q1 FY2026Mar 31, 2026198M+50.2%
Q4 FY2025Dec 31, 2025187M+47.3%
Q3 FY2025Sep 30, 2025158M+32.6%
Q2 FY2025Jun 30, 2025155M+30.4%
Q1 FY2025Mar 31, 2025132M+21.7%
Q4 FY2024Dec 31, 2024127M+22.6%
Q3 FY2024Sep 30, 2024119M+15.4%
Q2 FY2024Jun 30, 2024119M+15.3%
Q1 FY2024Mar 31, 2024108M+4.8%
Q4 FY2023Dec 31, 2023104M+0.4%
Q3 FY2023Sep 30, 2023103M+0.4%
Q2 FY2023Jun 30, 2023103M-0.5%
Q1 FY2023Mar 31, 2023103M+0.3%
Q4 FY2022Dec 31, 2022103M+134.7%
Q3 FY2022Sep 30, 2022103M+1634.1%
Q2 FY2022Jun 30, 2022104M+1668.7%
Q1 FY2022Mar 31, 2022103M+1677.0%
Q3 FY2021Sep 30, 202144M+659.3%
Q2 FY2021Jun 30, 20216M–
Q1 FY2021Mar 31, 20216M–
Q4 FY2020Dec 31, 20206M–
Q3 FY2020Sep 30, 20206M–

More Humacyte figures

See a number that looks wrong?